MAMohammad Al-Ani

Mohammad Al-Ani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammad Al-Ani has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Juan M. Aranda

    Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States of America

    3 shared publications
  • Juan Vilaro

    Division of Cardiovascular Medicine, Department of Medicine, Gainesville, Florida, USA

    3 shared publications
  • Mustafa M. Ahmed

    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA

    3 shared publications
  • Seri Hanayneh

    College of Medicine, University of Florida, Gainesville, FL, United States of America

    3 shared publications
  • Aditi G.M. Patel

    College of Medicine, University of Florida, Gainesville, FL, United States of America

    2 shared publications
  • Alex M Parker

    Division of Cardiovascular Medicine, University of Florida College of Medicine , 1329 SW 16th Street, PO Box 100288, Gainesville, FL 32608 , USA

    2 shared publications

Latest Publications

  • Open Access

    Enhancing Frailty Assessments for Transcatheter Aortic Valve Replacement Patients Using Structured and Unstructured Data: Real-World Evidence Study

    by Mamoun T Mardini, Chen Bai, Anthony A Bavry, Ahmed Zaghloul, R David Anderson, Catherine E Crenshaw Price, Mohammad A Z Al-Ani

    Background: Transcatheter aortic valve replacement (TAVR) is a commonly used treatment for severe aortic stenosis. As degenerative aortic stenosis is primarily a disease afflicting older adults, a frailty assessment is essential to patient selection and optimal periprocedural outcomes. Objective: This study aimed to enhance frailty assessments of TAVR candidates by integrating real-world structured and unstructured data. Methods: This study analyzed data from 14,000 patients between January 2018 and December 2019 to assess frailty in TAVR patients at the University of Florida. Frailty was identified using the Fried criteria, which includes weight loss, exhaustion, walking speed, grip strength, and physical activity. Latent Dirichlet allocation for topic modeling and Extreme Gradient Boosting for frailty prediction were applied to unstructured clinical notes and structured electronic health record (EHR) data. We also used least absolute shrinkage and selection operator regression for feature selection. Model performance was rigorously evaluated using nested cross-validation, ensuring the generalizability of the findings. Results: Model performance was significantly improved by combining unstructured clinical notes with structured EHR data, achieving an area under the receiver operating characteristic curve of 0.82 (SD 0.07), which surpassed the EHR-only model’s area under the receiver operating characteristic curve of 0.64 (SD 0.08). The Shapley Additive Explanations analysis found that congestive heart failure management, back problems, and atrial fibrillation were the top frailty predictors. Additionally, the latent Dirichlet allocation topic modeling identified 7 key topics, highlighting the role of specific medical treatments in predicting frailty. Conclusions: Integrating unstructured clinical notes and structured EHR data led to a notable enhancement in predicting frailty. This method shows great potential for standardizing frailty assessments using real-world data and improving patient selection for TAVR.


  • Open Access

    Natural recovery of cardiac allograft diastolic function, a retrospective longitudinal report

    by Shengyi Fu, Aditi G.M. Patel, Mohammed Ruzieh, Seri Hanayneh, Juan Vilaro, Mustafa M. Ahmed, Juan M. Aranda, Alex M. Parker, Mark S. Bleiweis, Jeffrey P. Jacobs, et al.

  • Developing and validating an electronic health record-based frailty index in pre-operative settings using machine learning

    by Chen Bai, Mohammad Al-Ani, Shawna Amini, Patrick Tighe, Catherine Price, Todd Manini, Mamoun Mardini


  • Open Access

    A case of ultra-prolonged intra-aortic balloon pump support via sheathless femoral access

    by Mohammad A Al-Ani, Garrett Snipes, Alex M Parker, Richard A Kerensky

    Background: An intra-aortic balloon pump (IABP) is a mechanical circulatory support platform with a relatively low complication rate. Axillary access is increasingly utilized to allow rehabilitation. Case summary: We present a case of femoral IABP inserted into the femoral artery percutaneously via a sheathless technique that allowed the patient to ambulate and physically rehabilitate over 102 days until cardiac transplantation. The patient was able to progress with the protocolized rehabilitation programme to up to 3500 ft walking distance. The IABP was removed at the time of transplantation without any vascular complications. Discussion: While axillary IABP offers an opportunity to rehabilitate, it has an unacceptably high complication rate, often resulting in vascular injury that adds morbidity to an acutely ill cohort. In this case, we found that sheathless femoral IABP access offered stability for a prolonged time while avoiding pain, bleeding, infection, and vascular injury. We hypothesize that this is due to less indwelling prosthetic material usage and also device flexibility, allowing conformation to the natural course of the femoral artery. We are encouraged by this case to use a sheathless access approach for patients expected to require prolonged IABP support.


  • Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types

    by Jeffery Budweg, Mohammad Al-Ani, Yazan Assaf, Alex Parker, Juan Aranda

    Amyloid transthyretin amyloidosis usually presents with cardiac amyloidosis manifestations, most commonly with a heart failure syndrome. The history and physical examination offer clues of other cardiac and extracardiac manifestations. Taking a detailed history is essential in elucidating pertinent family and medical history that may increase suspicion for amyloidosis. Further, certain findings on electrocardiogram and imaging should raise suspicion and trigger further workup that can confirm the diagnosis, since treatment is evolving.

  • Recovery Of Allograft Right Ventricular Diastolic Dysfunction Post Heart Transplantation

    by Seri Hanayneh, Aditi G.M. Patel, Shengyi Fu, Mustafa M. Ahmed, Juan Vilaro, Juan M. Aranda, Eric I. Jeng, Mark S. Bleiweis, Alex M. Parker, Mohammad A. Al-Ani

  • Outcome Of Patients With Systolic Heart Failure Undergoing Cardiac Sympathetic Denervation For Ventricular Arrhythmia

    by Steven M. Brady, Eldon L. Matthia, Steve M. Antoine, Juan M. Aranda, Mustafa M. Ahmed, Juan R. Vilaro, Mohammad A.Z. Al-Ani, Olusola Oduntan, Alex M. Parker

  • Open Access

    Left Ventricular Strain Is Associated With Myocardial Recovery Following ST-Elevation Myocardial Infarction, a Prospective Longitudinal CMR Study

    by Mohamad B. Taha, Eric I. Jeng, Michael Salerno, Diego Moguillansky, Ellen C. Keeley, Mohammad A. Al-Ani

    Background: Infarct size following ST-elevation myocardial infarction (STEMI) is an important determinate of left ventricular (LV) dysfunction and cardiovascular morbidity and mortality. Cardiac magnetic resonance feature tracking (CMR-FT) is a technique that allows for the assessment of myocardial function via quantification of longitudinal, radial, and circumferential strain. We investigated the association between CMR-FT-derived myocardial global strain and myocardial recovery.Methods: A prospective study on patients presenting with STEMI treated with primary percutaneous coronary intervention (PCI) was conducted. CMR imaging was obtained at two interval time points, the baseline within 2 weeks of hospital discharge and follow-up at 6 months. Strain analysis was performed via FT-CMR, and recovery was quantified by the area of late gadolinium enhancement (LGE).Results: A total of n = 14 patients met inclusion and exclusion criteria and were analyzed. There was a significant reduction in the infarct size, as measured by LGE mass percentage of the left ventricular muscle mass, between the initial and follow-up CMR (19.7%, IQR 12.2–23.9 vs. 17.1%, IQR 8.3–22.5, p = 0.04). Initial strain parameters were inversely correlated with the initial edema mass and the decrease in LGE mass between the initial and follow-up CMR. All LV global strains had high accuracy for the prediction of a reduction in LGE mass by 50% or more.Conclusions: LV global strains measured after primary PCI can predict the extent of myocardial recovery.


  • Impact of Laparoscopic Sleeve Gastrectomy on Cardiovascular Pharmacotherapy in Left Ventricular Assist Device Patients

    by Mohammad A. Al-Ani, Melissa R. Murray, Mohamad Badie Taha, Lauren Aprn Meece, Abdelrahman H. Elsayed, Eric I. Jeng, George J. Arnaoutakis, Yu Dnp Wu, Jeffrey E. Friedman, Juan R. Vilaro, et al.

    Left ventricular assist device (LVAD) implantation is increasingly utilized in patients with advanced heart failure and morbid obesity. Laparoscopic sleeve gastrectomy (LSG) can facilitate weight loss in this population and can ultimately change the pharmacokinetics of heart failure therapeutics. In this study, we aimed to explore the changes in cardiovascular pharmacotherapy post LSG intervention. We conducted a retrospective observational cohort study of morbidly obese LVAD patients between 2013 and 2019 at the University of Florida with available pharmacotherapeutic data at 1 and 6 months. Thirteen post-LSG patients and 13 control subjects were included in the final analysis. In the post-LSG group, the mean body mass index decreased significantly (44 ± 5 vs. 34 ± 4.9, P < 0.001), and 7 patients were successfully bridged to cardiac transplantation. Only 3 patients required adjustment of their LVAD speed. Mean return to flow decreased by 8 mm Hg, despite a 45% reduction in the mean number of vasodilators per patient (1.2 vs. 0.7, P = 0.03). Mean weekly warfarin dose decreased by 35% after 6 months (32.9 ± 20.9 vs. 50.7 ± 26.6, P = 0.01). The use of diuretics, vasodilators, and beta-blockers was significantly reduced by 50%, 45%, and 35%, respectively. None of these changes were observed in the control group at 6-month follow-up post LVAD. In this single-center experience, weight loss post LSG is associated with decreased vasodilator, diuretic, and anticoagulant medication requirements in LVAD patients.


  • PSEUDOANEURYSM OF APICO-AORTIC CONDUIT DISGUISED AS ANEMIA

    by Seri Hanayneh, Joshua Furtney, Jeffrey H Diamond, Mohammad A Z Al-Ani, David Anderson